Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Inventory (2016 - 2026)

United Therapeutics' Inventory history spans 17 years, with the latest figure at $183.1 million for Q4 2025.

  • On a quarterly basis, Inventory rose 15.96% to $183.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $183.1 million, a 15.96% increase, with the full-year FY2025 number at $183.1 million, up 15.96% from a year prior.
  • Inventory hit $183.1 million in Q4 2025 for United Therapeutics, up from $176.5 million in the prior quarter.
  • Over the last five years, Inventory for UTHR hit a ceiling of $183.1 million in Q4 2025 and a floor of $88.2 million in Q1 2022.
  • Historically, Inventory has averaged $121.1 million across 5 years, with a median of $103.8 million in 2023.
  • Biggest five-year swings in Inventory: fell 5.89% in 2022 and later soared 41.23% in 2024.
  • Tracing UTHR's Inventory over 5 years: stood at $93.8 million in 2021, then grew by 8.74% to $102.0 million in 2022, then rose by 9.61% to $111.8 million in 2023, then soared by 41.23% to $157.9 million in 2024, then rose by 15.96% to $183.1 million in 2025.
  • Business Quant data shows Inventory for UTHR at $183.1 million in Q4 2025, $176.5 million in Q3 2025, and $169.2 million in Q2 2025.